Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PMI21
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Precision Molecular
Deal Size : Undisclosed
Deal Type : Agreement
IONETIX and PRECISION MOLECULAR Inc. Announce Supply Agreement for Astatine-211
Details : Astatine-211 is a high-energy alpha-emitting radioisotope that can have a very powerful therapeutic effect when combined with the right targeting molecule. PMI is developing an astatine-211 labeled inhibitor of prostate-specific membrane antigen (PSMA) k...
Product Name : PMI21
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
January 26, 2022
Lead Product(s) : PMI21
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Precision Molecular
Deal Size : Undisclosed
Deal Type : Agreement